Literature DB >> 33466455

Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer.

Debina Sarkar1, Sarah D Diermeier1.   

Abstract

Circular RNAs (circRNAs) are a class of non-coding RNAs that form a covalently closed loop. A number of functions and mechanisms of action for circRNAs have been reported, including as miRNA sponge, exerting transcriptional and translational regulation, interacting with proteins, and coding for peptides. CircRNA dysregulation has also been implicated in many cancers, such as breast cancer. Their relatively high stability and presence in bodily fluids makes cancer-associated circRNAs promising candidates as a new biomarker. In this review, we summarize the research undertaken on circRNAs associated with breast cancer, discuss circRNAs as biomarkers, and present circRNA-based therapeutic approaches.

Entities:  

Keywords:  biomarker; breast cancer; circular RNA (circRNA); non-coding RNA; therapeutic target

Year:  2021        PMID: 33466455      PMCID: PMC7838774          DOI: 10.3390/ncrna7010002

Source DB:  PubMed          Journal:  Noncoding RNA        ISSN: 2311-553X


  117 in total

1.  Exon-intron circular RNAs regulate transcription in the nucleus.

Authors:  Zhaoyong Li; Chuan Huang; Chun Bao; Liang Chen; Mei Lin; Xiaolin Wang; Guolin Zhong; Bin Yu; Wanchen Hu; Limin Dai; Pengfei Zhu; Zhaoxia Chang; Qingfa Wu; Yi Zhao; Ya Jia; Ping Xu; Huijie Liu; Ge Shan
Journal:  Nat Struct Mol Biol       Date:  2015-02-09       Impact factor: 15.369

2.  The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA Processing Machinery Is Limiting.

Authors:  Dongming Liang; Deirdre C Tatomer; Zheng Luo; Huang Wu; Li Yang; Ling-Ling Chen; Sara Cherry; Jeremy E Wilusz
Journal:  Mol Cell       Date:  2017-11-22       Impact factor: 17.970

3.  circRNA biogenesis competes with pre-mRNA splicing.

Authors:  Reut Ashwal-Fluss; Markus Meyer; Nagarjuna Reddy Pamudurti; Andranik Ivanov; Osnat Bartok; Mor Hanan; Naveh Evantal; Sebastian Memczak; Nikolaus Rajewsky; Sebastian Kadener
Journal:  Mol Cell       Date:  2014-09-18       Impact factor: 17.970

Review 4.  CDK1 in Breast Cancer: Implications for Theranostic Potential.

Authors:  Sepideh Izadi; Afshin Nikkhoo; Mohammad Hojjat-Farsangi; Afshin Namdar; Gholamreza Azizi; Hamed Mohammadi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Anticancer Agents Med Chem       Date:  2020       Impact factor: 2.505

5.  Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.

Authors:  M Cuello; S A Ettenberg; A S Clark; M M Keane; R H Posner; M M Nau; P A Dennis; S Lipkowitz
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

6.  Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.

Authors:  William W Du; Ling Fang; Weining Yang; Nan Wu; Faryal Mehwish Awan; Zhenguo Yang; Burton B Yang
Journal:  Cell Death Differ       Date:  2016-11-25       Impact factor: 15.828

Review 7.  Emerging roles of long non-coding RNAs in breast cancer biology and management.

Authors:  I Amelio; F Bernassola; E Candi
Journal:  Semin Cancer Biol       Date:  2020-06-30       Impact factor: 15.707

Review 8.  Circular RNAs in Cancer - Lessons Learned From microRNAs.

Authors:  Mihnea Dragomir; George A Calin
Journal:  Front Oncol       Date:  2018-05-28       Impact factor: 6.244

9.  The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

Authors:  Rui Yang; Lei Xing; Xiaying Zheng; Yan Sun; Xiaosong Wang; Junxia Chen
Journal:  Mol Cancer       Date:  2019-01-08       Impact factor: 41.444

10.  circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family.

Authors:  Xiaojin Song; Yiran Liang; Yuting Sang; Yaming Li; Hanwen Zhang; Bing Chen; Lutao Du; Ying Liu; Lijuan Wang; Wenjing Zhao; Tingting Ma; Chuanxin Wang; Qifeng Yang
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-07       Impact factor: 8.886

View more
  7 in total

Review 1.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

2.  Cost-Effective Transcriptome-Wide Profiling of Circular RNAs by the Improved-tdMDA-NGS Method.

Authors:  Ashirbad Guria; Priyanka Sharma; Nagesh Srikakulam; Akhil Baby; Sankar Natesan; Gopal Pandi
Journal:  Front Mol Biosci       Date:  2022-05-13

3.  Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis.

Authors:  Qiuli Wang; Dong Liang; Peng Shen; Yang Yu; Yuan Yan; Wei You
Journal:  Transl Oncol       Date:  2021-05-20       Impact factor: 4.243

4.  Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing.

Authors:  Hartmut Jahns; Rohan Degaonkar; Peter Podbevsek; Swati Gupta; Anna Bisbe; Krishna Aluri; John Szeto; Pawan Kumar; Sarah LeBlanc; Tim Racie; Christopher R Brown; Adam Castoreno; Dale C Guenther; Vasant Jadhav; Martin A Maier; Janez Plavec; Martin Egli; Muthiah Manoharan; Ivan Zlatev
Journal:  Nucleic Acids Res       Date:  2021-10-11       Impact factor: 16.971

Review 5.  Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications.

Authors:  Samia Afzal; Muhammad Hassan; Safi Ullah; Hazrat Abbas; Farah Tawakkal; Mohsin Ahmad Khan
Journal:  Front Mol Biosci       Date:  2022-02-21

6.  Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis.

Authors:  Pejman Morovat; Saman Morovat; Arash M Ashrafi; Shahram Teimourian
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.996

Review 7.  Circular RNAs as Potential Biomarkers in Breast Cancer.

Authors:  Fatima Domenica Elisa De Palma; Francesco Salvatore; Jonathan G Pol; Guido Kroemer; Maria Chiara Maiuri
Journal:  Biomedicines       Date:  2022-03-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.